Publication & Citation Trends
Publications
0 total
Preliminary Acute Toxicity Results of Locally Advanced Prostate Cancer Treated with MR-guided Radiotherapy
Cited by 0
Semantic Scholar
85P Adjuvant osimertinib in patients (pts) with stage IB–IIIA EGFR mutation-positive (EGFRm) NSCLC after complete tumour resection: ADAURA China subgroup analysis OA
Cited by 4
Semantic Scholar
155P BNT113 + pembrolizumab as first-line treatment in patients with unresectable recurrent/metastatic HNSCC: Preliminary safety data from AHEAD-MERIT OA
Cited by 18
Semantic Scholar
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC. OA
Cited by 125
Semantic Scholar
A plain language summary of results from the ADAURA study: osimertinib after surgery for patients who have early-stage EGFR-mutated non-small cell lung cancer. OA
Cited by 4
Semantic Scholar
Nivolumab plus low-dose ipilimumab as first-line therapy in microsatellite instability-high/DNA mismatch repair deficient metastatic colorectal cancer: Clinical update.
Cited by 50
Semantic Scholar
356MO Osimertinib adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence OA
Cited by 3
Semantic Scholar
LBA1 Osimertinib adjuvant therapy in patients (pts) with resected EGFR mutated (EGFRm) NSCLC (ADAURA): Central nervous system (CNS) disease recurrence OA
Cited by 10
Semantic Scholar
Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer. OA
Cited by 1,219
Semantic Scholar
Research Topics
Gastric Cancer Management and Outcomes
(9)
Colorectal Cancer Treatments and Studies
(8)
Cancer Immunotherapy and Biomarkers
(5)
Breast Cancer Treatment Studies
(4)
Lung Cancer Treatments and Mutations
(4)
Affiliations
AstraZeneca (United Kingdom)
European Organisation for Research and Treatment of Cancer
Roswell Park Comprehensive Cancer Center
Akdeniz University
Acıbadem University